Medicsight are industry leaders in the development of enterprise-wide computer-aided detection (CAD) software for use by the medical imaging community to aid in earlier detection of disease.
Medicsight's patented software solutions have been validated against one of the world's largest and most population-diverse databases of verified CT scan data to help clinicians confidently identify, measure, and analyse suspicious pathology on CT scans of the colon and lung.
The company's CAD products include ColonCAD™ for CT colonography and LungCAD™ for CT scans of the thorax. Both products integrate with advanced visualisation software. This allows clinical end users to perform either a 'second read' where CAD findings are displayed to the user after completion of an initial review of the CT scan data, or a 'concurrent read' where CAD findings are available to the end user during their initial review of the CT scan images, providing a CAD solution that can be matched to individual workflow requirements and productivity.
Medicsight continues to develop CAD software for a variety of conditions with the goal of assisting clinicians in the early detection of disease to ultimately improve patient outcomes.